Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two sitagliptin + metformin FDC tablet formulations under fed conditions in healthy Thai volunteers
TCTR20200604004Phase 1Completed
- Sponsor
- Novartis
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of sitagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novartis. Started Oct 2020; status: completed.
02
Drugs
sitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20200604004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200604004.